Vaccine Trials Ongoing in Locally Advanced Oligometastatic Prostate Cancer; The poly-ICLC trial seeks to develop a delivery mechanism to prostate cancer through different biomarkers.

Press/Media

Period19 Jan 2025

Media coverage

1

Media coverage

  • TitleVaccine Trials Ongoing in Locally Advanced Oligometastatic Prostate Cancer; The poly-ICLC trial seeks to develop a delivery mechanism to prostate cancer through different biomarkers.
    Media name/outletCancerNetwork
    Country/TerritoryUnited States
    Date19/01/25
    PersonsKetan Badani
View all 1
View less